Canakinumab in a subgroup of patients with COVID-19
Claudio Ucciferri, Antonio Auricchio, Marta Di Nicola, Nicola Potere, Antonio Abbate, Francesco Cipollone, Jacopo Vecchiet, Katia Falasca
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Canakinumab2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineGeographyInternal medicineOutbreakInfectious disease (medical specialty)AnakinraDiseaseInflammasome and immune disordersCOVID-19 Clinical Research StudiesHematological disorders and diagnostics